Therapy implications for the role of IL-21 in lupus

Expert Rev Clin Immunol. 2016;12(5):487-8. doi: 10.1586/1744666X.2016.1152183. Epub 2016 Feb 24.

Authors

Vincenzo Dinallo¹, Davide Di Fusco¹, Roberta Izzo¹, Giovanni Monteleone¹

Affiliation

¹ a Department of Systems Medicine , University of Rome Tor Vergata , Rome , Italy.

PMID: 26854362
DOI: 10.1586/1744666X.2016.1152183

No abstract available

Publication types

Editorial

MeSH terms

Animals
Disease Models, Animal
Drug Delivery Systems
Humans
Interleukins / antagonists & inhibitors*
Interleukins / genetics
Lupus Erythematosus, Systemic / physiopathology
Lupus Erythematosus, Systemic / therapy*
Mice

Substances

Interleukins
interleukin-21